Please note that the text below is not a full transcript and has not been copyedited. For more insight and commentary on these stories, subscribe to...
LYON, France — The drug zodasiran (formerly ARO-ANG3), which targets the production of a liver protein, substantially lowers triglyceride and a range of lipoprotein levels in...
LYON, France — The first oral small molecule anti–proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor appears to be effective in not only lowering low-density lipoprotein...
Replacing meat with plant-based meat alternatives (PBMAs) can improve cardiovascular disease risk factors, including low-density lipoprotein cholesterol (LDL-C), a review of randomized controlled trials suggested. Long-term...
LYON, France — Bempedoic acid ( Nexletol) is safe for people with obesity and is effective at lowering lipid levels and rates of major cardiovascular events,...
ORLANDO, Fla. — The glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide (Wegovy, Ozempic) reduced cardiovascular events and reduced the risk of progression to diabetes by 73%...
ORLANDO, Fla. — Patients with type 1 and 2 diabetes who delay treatment with recommended statin therapy to address the well-known high risk for cardiovascular (CV)...
Weight loss achieved through bariatric surgery lowered the risk of major adverse cardiovascular events (MACE) by 42% and all-cause mortality by 37% in people who were...
It seems intuitive that because people with type 2 diabetes (T2D) generally need to avoid sugar, clinicians should recommend eating foods and using recipes containing artificial...
The prevention of cardiovascular diseases is a significant public health problem. Systemic arterial hypertension is a well-recognized risk factor for cardiovascular diseases worldwide. At birth, most...
HOUSTON — Narcolepsy is associated with a significantly increased risk for cardiovascular disease (CVD) and major adverse cardiac events (MACEs), independent of common comorbid conditions and...
Safety Measures Clazakizumab was well tolerated, with the most common serious adverse events being serious infection (12.5% in the low-dose group, 9.4% in the medium-dose group,...